A Small Win in Cutting Drug Costs
The White House plans to reveal a new deal with Regeneron Pharmaceuticals on pricing for their drugs. This move comes after the company was one of the few chosen to negotiate. Regeneron, which makes treatments like the Covid-19 antibody combo, didn’t comment right away. Their stock price jumped ove